Skip to main content
. 2015 Dec 9;7(6):6566–6575. doi: 10.18632/oncotarget.6512

Table 2. Detectable differential miRNAs in the case and control patient group by microarray.

miRNA Fold change between Case vs. control Expression in case group
1 hsa-mir-1290 0.26 down
2 hsa-mir-342-5p 0.22 down
3 hsa-mir-1224-5p 0.23 down
4 hsa-mir-345 0.38 down
5 hsa-mir-1228 0.38 down
6 hsa-mir-1249 0.32 down
7 hsa-mir-1826 0.26 down
8 hsa-miR-1306 0.38 down
9 hsa-miR-188-5p 0.43 down
10 hsa-miR-320a 0.48 down
11 hsa-miR-320c 0.26 down
12 hsa-miR-365 0.31 down
13 hsa-miR-423-5p 0.35 down
14 hsa-miR-483-5p 0.25 down
15 hsa-miR-634 0.31 down
16 hsa-miR-671-5p 0.23 down
17 hsa-miR-939 0.24 down
18 hsa-miR-1246 2.22 up
19 hsa-miR-150 10.41 up
20 hsa-miR-574-5p 8.04 up